UPDATE: Team pitching plan for airport site calls off forum
A company that wants to build a $500 million medical center at the Indianapolis International Airport has suddenly postponed a community forum to explain the plan and answer questions.
A company that wants to build a $500 million medical center at the Indianapolis International Airport has suddenly postponed a community forum to explain the plan and answer questions.
Indianapolis-area residents would see their sewer rates rise by about $8.50 a month this year and another $2.50 a month next year under a settlement announced Thursday.
Athlete's Business Network, which wants to build a $500 million medical complex at the airport, had listed Scott Gorman as president of its substance-abuse unit. His name was removed after IBJ reported he did not hold a state license in addiction recovery or a college degree.
The utility said Monday it has reached a settlement agreement with the Indiana Utility Consumer Counselor and some consumer groups on its new plan, which calls for updating and replacing aging substations, utility poles, power lines and transformers.
The IU School of Medicine, which attracted more than $300 million in research funding last year, hopes a new biomedical incubator will help it convert knowledge into innovative products and technology.
The top brass at Dow Chemical and DuPont will not go away empty handed after their companies merge and then split into three independent companies. The golden parachutes are spelled out in a new filing.
The leadership team at Athlete’s Business Network, a startup that wants to develop a massive sports-medical complex near the Indianapolis International Airport, doesn’t have much experience in such projects.
Under the deal, Franciscan was financially accountable for what it would spend on care for about 60,000 patients who had Anthem benefits provided by its employers or purchased individually. Would it work?
A former clinic director and 30-year faculty member at the IU School of Dentistry in Indianapolis who was fired last year after students complained he inappropriately touched them is suing to get his job back, saying he was denied a fair hearing.
With prices tumbling for scrap metal, used paper and old plastic bottles, recycling firms around Indiana are watching revenue drop. Most are working harder to find buyers that will pay a decent price for their truckloads of materials. Some are idling operations.
The Indiana Biosciences Research Institute, set up just three years ago, announced Wednesday morning that it has been awarded grants of $80 million from the Lilly Endowment and $20 million from the Eli Lilly and Co. Foundation.
Are uninsured patients clogging the nation’s emergency rooms? A new report seems to throw water on that idea.
A vote on a proposal to build a $500 million medical complex at Indianapolis International Airport has been delayed so the board can take another look at the plan. The delay was announced after an IBJ story raised questions about the track record of the executive behind the plan.
The FDA approved 98 percent of all applications for high-risk medical devices last year. That was the highest rate in at least 15 years.
The erectile-dysfunction drug, made famous by a slew of quirky commercials, is facing performance issues of its own.
The top executive at an Indianapolis start-up that wants to build a $500 million medical complex at the Indianapolis International Airport launched a 200-location Dunkin' Donuts business that went bankrupt in 2009 and he filed for personal bankruptcy in 2013.
Indianapolis International Airport officials on Tuesday afternoon announced that a $500 million proposal to build a brain health complex was chosen as one of two winning bids for 428 acres of land at the airport.
A small utility cooperative’s plan aims to help spur development in unserved areas between Greenfield and Fortville.
The Bloomington company’s latest recall comes as the company is dealing with a deluge of product lawsuits.
National retail chains, mail-order firms, big-box stores and supermarkets rang up nearly three-quarters of all prescription drugs in the U.S. last year.